Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Athira Pharma Inc’s stock clocked out at $0.26, up 3.92% from its previous closing price of $0.25. In other words, the price has increased by $3.92 from its previous closing price. On the day, 0.78 million shares were traded.
Ratios:
To gain a deeper understanding of ATHA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.18 and its Current Ratio is at 4.18. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on September 19, 2024, Downgraded its rating to Neutral and sets its target price to $0.50 from $5 previously.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 02 ’25 when San Martin Javier sold 10,826 shares for $0.56 per share. The transaction valued at 6,083 led to the insider holds 35,841 shares of the business.
Litton Mark James sold 25,107 shares of ATHA for $14,108 on Jan 02 ’25. The President and CEO now owns 242,591 shares after completing the transaction at $0.56 per share. On Jan 02 ’25, another insider, CHURCH KEVIN, who serves as the CHIEF SCIENTIFIC OFFICER of the company, sold 8,510 shares for $0.56 each. As a result, the insider received 4,782 and left with 130,761 shares of the company.
Stock Price History:
Over the past 52 weeks, ATHA has reached a high of $3.67, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -28.46%, while the 200-Day Moving Average is calculated to be -76.45%.
Shares Statistics:
A total of 39.04M shares are outstanding, with a floating share count of 35.70M. Insiders hold about 8.55% of the company’s shares, while institutions hold 46.13% stake in the company.
